Cigna Boosts FY22 Adjusted Profit Forecast Yet Again On Strength In Evernorth Unit

  • Cigna Corporation's CI Q3 sales increased 2.4% to $45.3 billion, beating the consensus of $44.76 billion. Adjusted revenues were $45.4 billion, reflecting strong performance led by Evernorth.
  • Quarterly sales at Cigna's Evernorth unit rose about 6% to $35.70 billion, driven by strong growth in its specialty pharmacy services.
  • Growth in Evernorth drove revenue growth, while its insurance business managed to keep tight control on costs.
  • The medical care ratio, a measure of medical expenses against premiums collected, improved to 80.8% from 83.5% a year ago when there was a surge in COVID cases.
  • Total insurance customers rose 5.6% to nearly 18 million as an increase in commercial insurance memberships softened the blow from a decline in government-backed plans.
  • Guidance: Cigna now expects adjusted income from operations of at least $23.10 per share compared with a prior forecast of at least $22.90 per share. Analysts expect a full-year profit of $23 per share.
  • It projects FY22 revenues of at least $179 billion (at least $178 billion expected earlier)
  • For FY22, the company expects total Medical Customer Growth (lives) of at least 900,000, up from the 800,000 anticipated earlier.
  • Price Action: CI shares are up 1.39% at $325.31 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!